10 hours ago | San Diego Biotechnology | 2 articles
Competitive:
Pfizer:
The Cancer Immunology Discovery group in La Jolla, CA is focused on the generation of large molecule immunotherapeutics that promote anti-tum...
La Jolla...
Read more ...
19 hours ago | San Diego Biotechnology | 7 articles
Fate Therapeutics, Inc.:
Fate Therapeutics is seeking a highly motivated stem cell biologist, preferably with hematopoietic and lymphocyte development experience, to join...
Read more ...
22 hours ago | San Diego Biotechnology
LA JOLLA-The Salk Institute received a matching $1 million gift from the BioMed Realty Management Team, which was used to fund the recruitment of award-winning cancer...
Read more ...
1 day ago | San Diego Biotechnology
Yoh, a Day & Zimmermann Company:
Ideal has 15+ years of Drug Discovery experience and are committed cancer researchers that develop transformational therapies for cancer...
Read more ...
2 days ago | San Diego Biotechnology
Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score , for...
Read more ...
2 days ago | Fierce Biotech
Merck KGaA offloads clinical-phase cancer drugs to Day One ntaylor
Tue, 02/23/2021 - 08:50
Read more ...
2 days ago | San Diego Biotechnology
SAN DIEGO--Biocept and Protean BioDiagnostics Collaborate to Demonstrate Advantages of Biocept's Target Selector Assay for Non-Small Cell Lung Cancer Patients....
Read more ...
2 days ago | San Diego Biotechnology | 8 articles
Is a fast growing, clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly...From Sorrento...
Read more ...
2 days ago | Gene Therapy
Posted on: 22 February 2021,
A company has stopped its clinical studies of a promising gene therapy for the blood disorder sickle cell disease after two people who...
Read more ...
2 days ago | San Diego Biotechnology | 2 articles
Position Summary: The Senior Scientist/Principal Scientist is responsible for developing next generation therapeutics to treat cancer using DNAtrix's oncolytic viral platform...
Read more ...
Register you to post on BioTech Mag
Free Registration
Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...
Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...
This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...
MEDICINE/Pulmonary Salary commensurate with qualifications and experienceFiling Deadline: Thu 3/11/2021... Read more ...
In this literature review, the antipathogenic properties and contact-mediated antibacterial and antiviral performance of copper cold spray surfaces are assessed and compared... Read more ...
Ribonucleic acid is key to various fundamental biological processes. It transfers genetic information, translates it into proteins or supports gene regulation. To achieve a... Read more ...
Imaging of the same spot shows that cracks eventually self-heal, an important trademark that maintains the integrity of structured liquids. Real-time video of 70 nm... Read more ...
Scientists have identified the specialized environment, known as a niche, in the bone marrow where new bone and immune cells are produced. The study also shows that... Read more ...
Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche ntaylor Thu, 02/25/2021 - 08:36 Read more ...
Overcoming chemotherapy resistance in leukemia with a diarrhea drug from Merck arlene.weintraub Thu, 02/25/2021 - 08:25 Read more ...
AbstractMotivationGenome data is a subject of study for both biology and computer science since the start of the Human Genome Project in 1990. Since then, genome sequencing for... Read more ...